Skip to main content
OpenTrials
Completed

NCT Number: NCT02564341

Targeting Effective Analgesia in Clinics for HIV - Intervention

The TEACH randomized controlled trial will test the effectiveness of a collaborative care intervention directed towards physicians who provide care for HIV-infected persons to improve the quality of care for prescribing chronic opioid therapy (COT) for pain and reduce the misuse of prescription opioids among HIV-infected persons.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The "Targeting Effective Analgesia in Clinics for HIV" (TEACH) Study will test the effectiveness of a collaborative care intervention directed toward HIV physicians to improve the management of chronic opioid therapy (COT) and reduce the misuse of prescription opioids among HIV-infected persons.

The intervention is composed of the following elements: 1) collaboration with an IT enabled nurse care manager; 2) physician education and academic detailing; and 3) facilitated access to a specialist in addictions to help manage the most challenging HIV-infected patients on COT. The nurse care manager will utilize an electronic registry to assist physicians in implementing guideline-driven care including opioid treatment agreements, urine drug testing (UDT), random pill counts and checking of online Prescription Monitoring Programs (PMPs). Physicians in the control group will receive information summarizing guidelines for COT but will not have access to the support of the TEACH intervention. This study is multi-site and will be conducted at Boston Medical Center and Grady Hospital (teaching hospital of Emory University). The 2-site study will use a cluster randomized trial design, randomized at the level of the physician, and compare primary outcomes over one year. The Specific Aims are to test the effectiveness of the TEACH collaborative care program to achieve the following: Aim 1 - to test whether the TEACH collaborative care program improves HIV physicians' adherence to guidelines for prescribing COT compared to standard practice; Aim 2 - to assess whether patient level outcomes improve as a result of the TEACH intervention; Aim 3 - to test whether the intervention increases HIV physicians' satisfaction with prescribing COT; and Aim 4 - to assess whether the intervention improves virologic control among HIV-infected patients who are on COT. If effective, implementation of the intervention in HIV clinics will enable physicians in clinical teams to deliver chronic opioid therapy according to established guidelines with more confidence, potentially resulting in less prescription drug abuse and improved HIV outcomes.

There are two distinct components to the study. The intervention, outlined in this Clinical Trials Protocol Registration and Results System (PRS) summary, involves consenting physicians as participants in a randomized controlled trial of an intervention and, via a waiver of informed consent, extracting patient level data on the physicians' patients from the electronic medical record. The patient cohort component, which is outlined in a separate Clinical Trials PRS summary, will involve recruiting and consenting patients in the HIV clinic on COT to be participants in an observational study, which will involve interviewing them to collect self-reported data and conducting medical chart reviews.

If effective, implementation of the TEACH intervention in clinics will enable physicians who provide primary care to HIV-infected patients in clinical teams to deliver chronic opioid therapy according to established guidelines with more confidence, potentially resulting in less prescription drug abuse and improved HIV outcomes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Physician Inclusion Criteria:

  • Physician (i.e. MD, DO) or Advanced Practice Provider (i.e., Nurse Practitioner or Physicians Assistant) at enrollment sites.
  • Main provider for ≥ 1 HIV-infected patient on COT (defined as having received ≥ 3 opioid prescriptions at least 21 days apart within a 6 month period).

Physician Exclusion Criteria:

  • Investigator on this study.
  • Planning to leave clinic < 9 months from enrollment.

Patient Inclusion Criteria:

  • COT patient ages ≥ 18 who are patients of physicians enrolled in the TEACH study.

Patient Exclusion Criteria:

  • None

Treatment and study plan

Collaboration with an IT enabled nurse care manager

Behavioral

The nurse care manager at each site will collaborate with intervention physicians to implement key essential elements of guideline driven care, namely opioid treatment agreements, urine drug testing, random pill counts and periodic checking of on-line Prescription Monitoring Programs. The nurse care manager will use an electronic registry to retrieve pain medication information from the electronic medical record (EMR). Registry data will be collected on the patients of the intervention group providers. The nurse care manager will be able to use the registry to generate reports that will allow him/her to monitor those patients who are receiving opioids for chronic pain.

Education and academic detailing

Behavioral

All intervention participants will receive a 60 minute group didactic session by a national expert on opioid prescribing for pain. Physicians will receive two academic detailing sessions, and will be given the option of having a third, booster academic detailing session if desired.

Facilitated access to a specialist in addictions

Behavioral

The nurse care manager will encourage and arrange referral of challenging patients with potential abuse or dependence to prescription opioids to an addiction specialist.

Primary outcomes

  1. Patient receipt of ≥2 UDT (Electronic Medical Record (EMR) extraction)

    Time frame: 12 Months

  2. % of patients who have ≥1 early refill (i.e., any early refills) (EMR extraction)

    Time frame: 12 Months

  3. Physician satisfaction managing HIV-infected patients on COT for pain (Physician self-report)

    Time frame: 12 Months

Secondary outcomes

  1. ≥3 primary care visits in infectious disease clinic (EMR extraction)

    Time frame: 12 Months

  2. % of patients who had a discontinuation of their narcotic prescriptions (EMR extraction)

    Time frame: 12 Months

  3. Opioid treatment agreement (EMR extraction)

    Time frame: 12 Months

  4. % of physicians who self-report consulting the state Prescription Monitoring Program (Physician self-report)

    Time frame: 12 Months

  5. Number (continuous measure) of early refills at 12 months (EMR extraction)

    Time frame: 12 Months

  6. Patient aberrant use (Patient self-report)

    Time frame: 12 Months

  7. Number of patients who have visited the emergency department to seek opioids (EMR extraction and patient self-report)

    Time frame: 12 Months

  8. Patient pain severity and interference (Patient self-report)

    Time frame: 12 Months

  9. Patient addiction severity (Patient self-report)

    Time frame: 12 Months

  10. Physician confidence in prescribing COT (Physician self-report)

    Time frame: 12 Months

  11. Patient satisfaction with COT (Patient self-report)

    Time frame: 12 Months

  12. Patient trust in physician (Patient self-report)

    Time frame: 12 Months

Other outcomes

  1. Undetectable HIV viral load (EMR extraction)

    Time frame: 12 Months

  2. Cluster of differentiation 4 (CD4) cell count (EMR extraction)

    Time frame: 12 Months

Sponsors and collaborators

Lead sponsor

Boston Medical Center

Other

Collaborators

  • Emory University
  • Grady Health System
  • National Institute on Drug Abuse (NIDA)

Registry information

Official study title

Collaborative Care Intervention to Improve Providers' Opioid Prescribing for HIV-infected Patients - Intervention Component

Acronym: TEACH

Important dates

Study start
2015
Primary completion
2018
Study completion
2018
First posted
Sep 30, 2015
Registry last updated
Nov 20, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.